EUVIMEDEUVIMED entdecken
Klinische Studie

Injectable Ketoprofen VS. Acetylsalicylic Acid for the Relief of Severe Cancer Pain: A Double-Blind, Crossover Trial

G Sacchetti, P Camera, A P Rossi, A Martoni, G Bruni, F Pannuti

Drug Intelligence & Clinical Pharmacy · 1984-05 · 18 (5) · 403-406

DOI: 10.1177/106002808401800510 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Drug Intelligence & Clinical Pharmacy, online erschienen am 01.05.1984. Verfasst von G Sacchetti und 5 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thirty-six patients suffering from severe pain due to bone involvement from cancer participated in an analgesic study that compared single doses of ketoprofen 100 or 400 mg iv or injectable acetylsalicylic acid 1 g. A double-blind, balanced incomplete block design was adopted, in which each patient received two of the three test treatments, with an interval of 24 hours. Ketoprofen 400 mg proved significantly superior to 100 mg of the same drug, and was superior to 1 g of the acetylsalicylic acid derivative in the patients' assessment of the overall response. This was expressed by a visual analog scale and preferences. No adverse reaction was observed with any treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAspirinClinical Trials as TopicDouble-Blind MethodFemaleHumansInjections, IntravenousKetoprofenMaleMiddle AgedNeoplasmsPainPhenylpropionates

Substanzen

PhenylpropionatesKetoprofenAspirin

Zitieren

APA

Sacchetti, G., Camera, P., Rossi, A. P., Martoni, A., Bruni, G., & Pannuti, F. (1984). Injectable Ketoprofen VS. Acetylsalicylic Acid for the Relief of Severe Cancer Pain: A Double-Blind, Crossover Trial. Drug Intelligence & Clinical Pharmacy, 18(5), 403-406. https://doi.org/10.1177/106002808401800510

Vancouver

Sacchetti G, Camera P, Rossi AP, Martoni A, Bruni G, Pannuti F. Injectable Ketoprofen VS. Acetylsalicylic Acid for the Relief of Severe Cancer Pain: A Double-Blind, Crossover Trial. Drug Intelligence & Clinical Pharmacy. 1984;18(5):403-406. doi:10.1177/106002808401800510

BibTeX
@article{Sacchetti1984,
  author = {Sacchetti, G and Camera, P and Rossi, A P and Martoni, A and Bruni, G and Pannuti, F},
  title = {Injectable Ketoprofen VS. Acetylsalicylic Acid for the Relief of Severe Cancer Pain: A Double-Blind, Crossover Trial},
  journal = {Drug Intelligence & Clinical Pharmacy},
  year = {1984},
  volume = {18},
  number = {5},
  pages = {403--406},
  doi = {10.1177/106002808401800510}
}
Kostenlos starten →